Lupin gets USFDA nod for Asthma drug

Quoting IQVIA MAT September data, Lupin said, the said Asthma drug had annual sales of around USD 474.5 million in the US.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OGRovz
via IFTTT

0 comments:

Post a Comment